A randomized double-blind placebo-controlled trial of oliceridine, a G protein-biased ligand at the µ-opioid receptor, for management of moderate-to-severe acute pain following bunionectomy.

Oliceridine provided rapid and significant pain relief after bunionectomy in Korean patients, with no serious adverse events reported, supporting its potential as an effective and well-tolerated analgesic option.